Based on the available information, there is no explicit statement or evidence suggesting that receiving vaccines during Cosentyx (secukinumab) treatment is unsafe. However, it is always recommended to consult with a healthcare professional before making decisions regarding vaccinations while on any medication.

Cosentyx is a medication used to treat various conditions such as plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis [1]. The drug's official website, Cosentyx.com, provides information on COVID-19 and Cosentyx, stating that "there is no evidence that Cosentyx affects how well COVID-19 vaccines work" [2]. However, it does not explicitly address the safety of receiving other vaccines while on Cosentyx treatment.

A study published in the National Center for Biotechnology Information (NCBI) found that "the use of biologic agents, including secukinumab, during the COVID-19 pandemic has been considered safe and effective" [3]. While this study focuses on COVID-19 vaccines and secukinumab, it does not mention any potential risks or concerns associated with receiving other vaccines during Cosentyx treatment.

In summary, there is no evidence suggesting that receiving vaccines during Cosentyx treatment is unsafe. Nevertheless, it is crucial to consult a healthcare professional before making decisions regarding vaccinations while on any medication.

Sources:
[1] DrugPatentWatch.com. (n.d.). Biologics: Tradename: COSENTYX. Retrieved from <https://www.drugpatentwatch.com/p/biologics/tradename/COSENTYX>
[2] Cosentyx.com. (n.d.). COVID-19. Retrieved from <https://www.cosentyx.com/all/covid19>
[3] Gisondi, P., Vaglio, A., & Atzeni, F. (2022). Management of Rheumatic Diseases During the COVID-19 Pandemic: Focus on Biologic and Targeted Synthetic Disease-Modifying Antirheumatic Drugs. Frontiers in Medicine, 9, 831515. doi:10.3389/fmed.2022.831515